Vantive Health LLC clinical trials
Formerly part of Baxter Healthcare Corporation, Jan 31, 2025 · source ↗
The registry lists 55 studies whose lead sponsor is Vantive Health LLC. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.
Before and after it left Baxter Healthcare Corporation
- First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- 52
- First submitted after Vantive Health LLC left Baxter Healthcare Corporation
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Vantive Health LLC55 studies
Something wrong with this grouping? Tell us on the Baxter Healthcare Corporation page.
Studies
Recruiting first, then most recently updated. Showing 50 of 55. List all 55 → · All Baxter Healthcare Corporation studies →
- Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRTRecruitingNCT05399537Phase 3
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+RecruitingNCT07326215Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted after Vantive Health LLC left Baxter Healthcare Corporation
- Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis ModalitiesRecruitingNCT07781124
Sponsor listed in the registry: Vantive Health LLC · First submitted after Vantive Health LLC left Baxter Healthcare Corporation
- Observational Study of the Use of Extraneal in Peritoneal Dialysis in PatientsCompletedNCT06492031
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement TherapyCompletedNCT06983509
Sponsor listed in the registry: Vantive Health LLC · First submitted after Vantive Health LLC left Baxter Healthcare Corporation
- Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in ChinaTerminatedNCT01413074Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT RegistryCompletedNCT06633029
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Post-Market Study of Low-flow ECCO2R Using PrismaLung+CompletedNCT04617093Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big DialyzerCompletedNCT00659724
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Study of How the Dose of Dialysis is Affected by Dialysate Flow RateCompletedNCT00962000Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) PatientsCompletedNCT01219959Phase 3
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)TerminatedNCT02860130Phase 3
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD PatientsCompletedNCT00567489Phase 4
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD PatientsCompletedNCT00567398Phase 3
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Heart Failure and Peritoneal UltrafiltrationTerminatedNCT00368641Phase 2
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Theranova Randomized, Controlled, Trial (RCT) in ChinaCompletedNCT05309291Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Molecule Removal and Ease of Use: A Comparison of Two Different DialyzersCompletedNCT00636389Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) PatientsCompletedNCT03257410Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For HemodialysisCompletedNCT00636077Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)TerminatedNCT03812679Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in ChildrenTerminatedNCT02561247Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- HepZero:Heparin Free Dialysis With EvodialCompletedNCT01318486Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Myoglobin Removal by High Cut-off CVVHDCompletedNCT01467180Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect CatheterCompletedNCT05888376
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)CompletedNCT03859830Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to HemodiafiltrationCompletedNCT03499691Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)CompletedNCT01783626Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- HemoControl System Activated in Hemodiafiltration TreatmentsCompletedNCT01582867Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- A Pilot Study of a Heparin Dosing Algorithm for HemodialysisCompletedNCT01181544Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF ModeCompletedNCT02377622Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac SurgeryWithdrawnNCT01579396Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Automated Setting of Individualized Sodium TechnologyCompletedNCT02795286Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/or Encephalopathy and/or Renal FailureCompletedNCT00614146Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Clinical Assessment of a New Catheter Surface Coating With Antimicrobial PropertiesCompletedNCT00621712Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- PERCI- Medium Cut Off (MCO)CompletedNCT02084381Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Quality of Life on Peritoneal Dialysis Versus Hemodialysis in ChinaCompletedNCT02378350Phase 4
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to HemodiafiltrationCompletedNCT03547336Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Reduction of Heparin Dose in Dialysis With Evodial SystemCompletedNCT00781690Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 DialyzerCompletedNCT03547323Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Performance Comparison of Revaclear With Larger DialyzerCompletedNCT01722695Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis ApplicationCompletedNCT00621114Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis ModeCompletedNCT02377570Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Effect of HCO1100 on Cardiovascular FunctionTerminatedNCT01363921Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic ShockCompletedNCT00922870Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Permeability Enhancement to Reduce Chronic InflammationCompletedNCT01582893Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off HemodialysisCompletedNCT01526798Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IRWithdrawnNCT01093547Phase 4
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic ShockTerminatedNCT00875888Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood LineCompletedNCT00804453Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation
- Gambro AK200 ULTRA Hemodiafiltration StudyCompletedNCT01202708Not applicable
Sponsor listed in the registry: Vantive Health LLC · First submitted before Vantive Health LLC left Baxter Healthcare Corporation